Cargando…
Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30
Epstein‐Barr virus‐related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein‐Barr virus (EBV) local proliferation and thus could be an interesting target. Br...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303872/ https://www.ncbi.nlm.nih.gov/pubmed/32577242 http://dx.doi.org/10.1002/ccr3.2721 |
_version_ | 1783548153450987520 |
---|---|
author | Montes, Lydia Tredez, Estelle Yzet, Clara Delette, Caroline Chatelain, Denis Lebon, Delphine Fumery, Mathurin Marolleau, Jean‐Pierre |
author_facet | Montes, Lydia Tredez, Estelle Yzet, Clara Delette, Caroline Chatelain, Denis Lebon, Delphine Fumery, Mathurin Marolleau, Jean‐Pierre |
author_sort | Montes, Lydia |
collection | PubMed |
description | Epstein‐Barr virus‐related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein‐Barr virus (EBV) local proliferation and thus could be an interesting target. Brentuximab vedotin could become a new helpful tool. |
format | Online Article Text |
id | pubmed-7303872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73038722020-06-22 Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 Montes, Lydia Tredez, Estelle Yzet, Clara Delette, Caroline Chatelain, Denis Lebon, Delphine Fumery, Mathurin Marolleau, Jean‐Pierre Clin Case Rep Case Reports Epstein‐Barr virus‐related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein‐Barr virus (EBV) local proliferation and thus could be an interesting target. Brentuximab vedotin could become a new helpful tool. John Wiley and Sons Inc. 2020-04-08 /pmc/articles/PMC7303872/ /pubmed/32577242 http://dx.doi.org/10.1002/ccr3.2721 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Montes, Lydia Tredez, Estelle Yzet, Clara Delette, Caroline Chatelain, Denis Lebon, Delphine Fumery, Mathurin Marolleau, Jean‐Pierre Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title | Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title_full | Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title_fullStr | Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title_full_unstemmed | Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title_short | Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 |
title_sort | epstein‐barr virus‐related mucocutaneous ulcer lymphoma associated with crohn's disease, treated with monoclonal antibody anti‐cd30 |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303872/ https://www.ncbi.nlm.nih.gov/pubmed/32577242 http://dx.doi.org/10.1002/ccr3.2721 |
work_keys_str_mv | AT monteslydia epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT tredezestelle epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT yzetclara epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT delettecaroline epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT chatelaindenis epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT lebondelphine epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT fumerymathurin epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 AT marolleaujeanpierre epsteinbarrvirusrelatedmucocutaneousulcerlymphomaassociatedwithcrohnsdiseasetreatedwithmonoclonalantibodyanticd30 |